Effect of genistein against copper-induced lipid peroxidation of human high density lipoproteins (HDL)

Atherosclerosis

Volumn 172, Issue 1, 2004, Pages 55-61

  Ferretti, G ^a   Bacchetti, T ^a   Menanno, F ^a   Curatola, G ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Antioxidants; Genistein; High density lipoproteins; Lipid peroxidation

Indexed keywords

ALKADIENE; COPPER; GENISTEIN; HIGH DENSITY LIPOPROTEIN; LAURDAN; TRYPTOPHAN;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; NORMAL HUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN STRUCTURE; SPECTROFLUOROMETRY;

EID: 0347985756     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2003.09.020     Document Type: Article

References (30)

1. Anthony M.S., Clarkson T.B., Williams J.K. Effects of soy isoflavones on atherosclerosis: potential mechanisms. Am. J. Clin. Nutr. 68:1998;1390S-1393S.
2. Hertog M.G., Kromhout D., Aravanis C., Blackburn H., Buzine R., Fidanza F.et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch. Int. Med. 155:1995;381-386.
3. Liggins J., Runswick S., Bingham S.A. Daidzein and genistein content of cereals. Eur. J. Clin. Nutr. 56:2002;961-966.
4. Jha H.C., von Recklinghausen G., Zilliken F. Inhibition of in vitro microsomal lipid peroxidation by isoflavonoids. Biochem. Pharmacol. 34:1985;1367-1369.
5. Guo Q., Rimbach G., Moini H., Weber S., Packer L. ESR and cell culture studies on free radical-scavenging and antioxidant activities of isoflavonoids. Toxicology. 179:2002;171-180.
6. Ho K.P., Li L., Zhao L., Qian Z.M. Genistein protects primary cortical neurons from iron-induced lipid peroxidation. Mol. Cell. Biochem. 247:2003;219-222.
7. Kerry N., Abbey M. The isoflavone genistein inhibits copper and peroxyl radical mediated low density lipoprotein oxidation in vitro. Atherosclerosis. 140:1998;341-347.
8. Wilson T., March H., Ban W.J., Hou Y., Adler S., Mayers C.Y.et al. Antioxidant effects of phyto-and synthetic-estrogens on cupric ion-induced oxidation of human low-density lipoproteins in vitro. Life Sci. 70:2002;2287-2297.
9. Nofer J.R., Kehrel B., Fobker M., Levkau B., Assmann G., von Eckardstein A. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis. 161:2002;1-16.
10. Mackness M.I., Abbott C., Arrol S., Durrington P.N. The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation. Biochem. J. 294:1993;829-834.
11. Ferretti G., Taus M., Dousset N., Solera M.L., Valdiguié P., Curatola G. Physico chemical properties of copper oxidized high density lipoprotein: a fluorescence study. Biochem. Mol. Biol. Int. 30(4):1993;713-719.
12. Francis G.A. High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences. Biochim. Biophys. Acta. 1483:2000;217-235.
13. Chung B.H., Segrest J.P., Ray M.J., Brunzell J.D., HoKonson J.E., Krauss R.M. Single vertical spin density gradient ultracentrifugation. Method Enzimol. 128:1986;181-209.
14. Lowry O.H., Rosebrough N.J., Farr A.L., Randall P.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
15. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic. Res. Commun. 6(1):1989;67-75.
16. Dousset N., Ferretti G., Taus M., Valdiguie P., Curatola G. Fluorescence analysis of lipoprotein peroxidation. Methods Enzymol. 233:1994;459-469.
17. Parasassi T., De Stasio G., Ravagnan G., Rusch R.M., Gratton E. Quantitation of lipid phases in phospholipid vesicles by the generalized polarization of Laurdan fluorescence. Biophys. J. 60:1991;179-189.
18. Fiorini R., Curatola G., Kantar A., Giorgi P.L., Gratton E. Use of Laurdan fluorescence in studying plasma membrane organization of polymorphonuclear leukocytes during the respiratory burst. Photochem. Photobiol. 57:1993;438-441.
19. Ferretti G., Marchionni C., Bacchetti T., Galeazzi T., Dousset N. Effect of aluminium on lipid peroxidation of human high density lipoproteins. Free Radic. Res. 37:2003;515-521.
20. Patel R.P., Boersma B.J., Crawford J.H.et al. Antioxidant mechanisms of isoflavones in lipid systems: paradoxical effects of peroxyl radical scavenging. Free Radic. Biol. Med. 31:2001;1570-1581.
21. Mira L., Fernandez M.T., Santos M., Rocha R., Florencio M.H., Jennings K.R. Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic. Res. 36:2002;1199-1208.
22. Hwang J., Sevanian A., Hodis H.N., Ursini F. Synergistic inhibition of LDL oxidation by phytoestrogens and ascorbic acid. Free Radic. Biol. Med. 29:2000;79-89.
23. Abuja P.M., Lohner K., Prassl R. Modification of the lipid-protein interaction in human low-density lipoprotein destabilizes ApoB-100 and decreases oxidizability. Biochemistry. 38:1999;3401-3408.
24. Ferretti G., Bacchetti T., Bicchiega V., Curatola G. Effect of human Apo AIV against lipid peroxidation of very low density lipoproteins. Chem. Phys. Lipids. 114:2002;45-54.
25. Kaamanen M., Adlercreutz H., Jauhiainen M., Tikkanen M.J. Accumulation of genistein and lipophilic genistein derivatives in lipoproteins during incubation with human plasma in vitro. Biochim. Biophys. Acta. 1631:2003;147-152.
26. Barnes S., Sfakianos J., Coward L., Kirk M. Soy isoflavonoids and cancer prevention: underlying biochemical and pharmacological issues. Adv. Exp. Med. Biol. 401:1996;87-100.
27. Adlercreutz H., Markkanen H., Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet. 342:1993;1209-1210.
28. Gooderham M.H., Adlercreutz H., Ojala S.T., Wahala K., Holub B.J. A soy protein isolate rich in genistein and daidzein and its effects on plasma isoflavone concentrations, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men. J. Nutr. 126:1996;2000-2006.
29. Witztum J.L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88:1991;1785-1789.
30. Salonen J.T., Salonen R., Seppanen K., Kantola M., Suntioinen S., Korpela H. Interactions of serum copper, selenium, and low density lipoprotein cholesterol in atherogenesis. Br. Med. J. 302:1991;756-760.